Clinical Audit of Denosumab Biosimilar for Aggressive GCT of Bone: A Tertiary Care Center Retrospective Analysis

مواد مشابهة

• Phase III Study to Confirm Clinical Similarity of MB09, a Denosumab Biosimilar, and Prolia^® in Postmenopausal Women with Osteoporosis (SIMBA Study)
  حسب: Jerzy Supronik, وآخرون
  منشور في: (2026-02-01)
• Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of CMAB807, a New Denosumab Biosimilar, in Healthy Chinese Subjects
  حسب: Hanjing Chen, وآخرون
  منشور في: (2022-01-01)
• A randomized trial comparing LY01011, biosimilar candidate, with the reference product denosumab (Xgeva®) in healthy Chinese subjects
  حسب: Yanhua Ding, وآخرون
  منشور في: (2023-10-01)
• A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of QL1206 to Denosumab Among Chinese Healthy Subjects
  حسب: Hong Zhang, وآخرون
  منشور في: (2020-10-01)
• Clinical Audit of Denosumab Biosimilar for Aggressive GCT of Bone: A Tertiary Care Center Retrospective Analysis
  حسب: Rajesh B. Singh, وآخرون
  منشور في: (2025-10-01)